« Previous
Next »
Placenta
Volume 29, Issue 9
, Pages 809-815
, September 2008
The Distribution of Angiopoietin-1, Angiopoietin-2 and Their Receptors Tie-1 and Tie-2 in the Very Early Human Placenta
References
- . Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004;25:114–126
- . Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;110(Suppl 1):S10–S18
- . The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25
- . Signaling vascular morphogenesis and maintenance. Science. 1997;277:48–50
- . Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost. 1997;78:672–677
- . Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors. 1994;11:105–111
- . Localisation of hepatocyte growth factor and its receptor (c-met) protein and mRNA in human term placenta. Growth Factors. 1996;13:133–139
- . Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997;18:657–665
- Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 1997;56:489–494
- . Angiogenic factors. Science. 1987;235:442–447
- . Angiogenesis and placental vasculature – a workshop report. Placenta. 2000;21(Suppl A):S69–S70
- . Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem. 1996;271:603–606
- . Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581–611
- . Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy. Mol Reprod Dev. 2008;75:504–511
- . Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Berlin: Springer-Verlag; 1999;
- Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. Faseb J. 2007;21:3171–3183
- Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin Cancer Res. 2001;7:918–927
- Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55–60
- . Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002;99:11205–11210
- . Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A. 2002;99:8219–8224
- . Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006;312:630–641
- . Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod. 2002;66:802–812
- . Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil. 1993;99:609–615
- . Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod. 1996;11:1090–1098
- Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta. 2004;25:560–572
- . Sequential steps during vasculogenesis and angiogenesis in the very early human placenta. Placenta. 2006;27:535–539
- . Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem. 2007;109:257–265
- Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem. 1994;54:56–66
- . Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors. 1997;15:69–80
- . Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Investig. 1997;4:169–177
- . Placental villous vascular endothelial growth factor expression and vascularization after estrogen suppression during the last two-thirds of baboon pregnancy. Endocrine. 2007;31:260–267
- . Pathology of the human placenta. New York: Springer; 2000;
- Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res. 1998;83:233–240
- . Placental expression of angiopoietin-1, angiopoietin-2 and tie-2 during placental development in an ovine model of placental insufficiency-fetal growth restriction. Pediatr Res. 2005;58:1228–1232
- Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol. 2000;156:2185–2199
- . Differential expression of placental villous angiopoietin-1 and -2 during early, mid and late baboon pregnancy. Placenta. 2007;28:212–218
- . Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab. 2002;87:4213–4224
- . Hofbauer cells in early human placenta: possible implications in vasculogenesis and angiogenesis. Placenta. 2007;28:841–845
- . In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells. Biochem Biophys Res Commun. 1999;264:133–138
PII: S0143-4004(08)00200-2
doi: 10.1016/j.placenta.2008.06.009
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
Placenta
Volume 29, Issue 9
, Pages 809-815
, September 2008
